We exploited microarray data to link ACC transcriptomics with pharmacological information previously obtained in ACC (h-TERT) tumor cells22, a well-established experimental model of ACC with epi-myoepithelial derivation, lacking p63 expression23. The gene discussed is TP63; the disease is adrenal cortex carcinoma.